To optimize care for patients with hemoglobinopathies, frequent screening for COVID-19 is prudent as viral kinetics in asplenic patients are unknown and differentiating prolonged viral shedding versus reinfection remains a challenge.
Keywords: COVID‐19 Reinfection; corona virus; hemoglobinopathies; thalassemia beta major.
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.